These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 18178791
21. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Kjeldsen SE, Julius S. Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303 [Abstract] [Full Text] [Related]
22. Management of cardiovascular risk with RAS inhibitor/CCB combination therapy. Dahlöf B. J Hum Hypertens; 2009 Feb; 23(2):77-85. PubMed ID: 18685606 [Abstract] [Full Text] [Related]
23. [Perfect 24-hr blood pressure control using self-measured blood pressure and ambulatory blood pressure monitoring in chronic kidney disease]. Kario K. Nihon Jinzo Gakkai Shi; 2009 Feb; 51(4):465-70. PubMed ID: 19601555 [No Abstract] [Full Text] [Related]
27. [Contribution of diuretics to the treatment of hypertension in patients with CKD]. Ura N, Yamaji I. Nihon Jinzo Gakkai Shi; 2009 Feb; 51(4):446-50. PubMed ID: 19601551 [No Abstract] [Full Text] [Related]
32. [Clinical trials on protective efficacy of antihypertensive agents for organ damage due to diabetes mellitus complicated with hypertension]. Higashiura K. Nihon Rinsho; 2004 Mar 08; 62 Suppl 3():623-7. PubMed ID: 15171446 [No Abstract] [Full Text] [Related]
33. Treatment of hypertension in chronic kidney disease. Toto RD. Semin Nephrol; 2005 Nov 08; 25(6):435-9. PubMed ID: 16298269 [Abstract] [Full Text] [Related]
34. Blood pressure control and prevention of stroke. Karthikeyan VJ, Lip GY. Expert Rev Neurother; 2006 Feb 08; 6(2):203-12. PubMed ID: 16466300 [Abstract] [Full Text] [Related]
36. [Blood pressure lowering therapy for mild hypertensive patients with a history of stroke]. Ishikawa E, Ibayashi S. Nihon Rinsho; 2008 Aug 08; 66(8):1560-5. PubMed ID: 18700558 [Abstract] [Full Text] [Related]
37. Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension. Tocci G, Sciarretta S, Facciolo C, Volpe M. Expert Rev Cardiovasc Ther; 2007 Jul 08; 5(4):767-76. PubMed ID: 17605654 [Abstract] [Full Text] [Related]
38. [Organ protection by angiotensin II receptor blockers]. Kumagai H, Onami T, Takimoto C, Iigaya K, Saruta T. Nihon Rinsho; 2004 Mar 08; 62 Suppl 3():569-73. PubMed ID: 15171437 [No Abstract] [Full Text] [Related]
39. [Management of hypertension in upheaval?]. Zidek W, Paul M. Dtsch Med Wochenschr; 2005 Nov 18; 130(46):2627. PubMed ID: 16281156 [No Abstract] [Full Text] [Related]